Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Lardinois, W. Weder, T. Hany, E. Kamel, S. Korom, B. Seifert, G. Schulthess, H. Steinert (2003)
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.The New England journal of medicine, 348 25
M. Gould, Sharfun Ghaus, J. Olsson, E. Schultz (2008)
Timeliness of care in veterans with non-small cell lung cancer.Chest, 133 5
M. Conron, S. Phuah, Daniel Steinfort, E. Dabscheck, G. Wright, D. Hart (2007)
Analysis of multidisciplinary lung cancer practiceInternal Medicine Journal, 37
V. Lowe, J. Hoffman, D. DeLong, E. Patz, R. Coleman (1994)
Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 35 11
K. Takamochi, J. Yoshida, K. Murakami, S. Niho, G. Ishii, M. Nishimura, Y. Nishiwaki, Kazuya Suzuki, K. Nagai (2005)
Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients.Lung cancer, 47 2
G. Antoch, J. Stattaus, A. Nemat, S. Marnitz, T. Beyer, H. Kuehl, A. Bockisch, J. Debatin, L. Freudenberg (2003)
Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.Radiology, 229 2
B. Dwamena, S. Sonnad, J. Angobaldo, R. Wahl (1999)
Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.Radiology, 213 2
P. Selby, P. Selby, C. Gillis, R. Haward (1996)
Benefits from specialised cancer careThe Lancet, 348
P. Shreve, Y. Anzai, R. Wahl (1999)
Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants.Radiographics : a review publication of the Radiological Society of North America, Inc, 19 1
C. Reed, D. Harpole, K. Posther, S. Woolson, R. Downey, B. Meyers, R. Heelan, H. Macapinlac, Sin-Ho Jung, G. Silvestri, B. Siegel, V. Rusch (2003)
Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.The Journal of thoracic and cardiovascular surgery, 126 6
H. Tinteren, O. Hoekstra, E. Smit, J. Bergh, A. Schreurs, R. Stallaert, P. Velthoven, E. Comans, Fred Diepenhorst, P. Verboom, J. Mourlk, P. Postmus, M. Boers, G. Teule (2002)
Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trialThe Lancet, 359
E. Salomaa, Susanna Sällinen, H. Hiekkanen, K. Liippo (2005)
Delays in the diagnosis and treatment of lung cancer.Chest, 128 4
A. Rajasekaran, D. Silvey, B. Leung, D. Honeybourne, R. Cayton, J. Reynolds, S. Trotter, M. Roland (2006)
Effect of a multidisciplinary lung investigation day on a rapid access lung cancer servicePostgraduate Medical Journal, 82
A. Moody, M. Muers, D. Forman (2004)
Delays in managing lung cancer.Thorax, 59 1
C. Mountain, C. Dresler (1997)
Regional lymph node classification for lung cancer staging.Chest, 111 6
V. Kalff, R. Hicks, M. MacManus, D. Binns, A. McKenzie, R. Ware, A. Hogg, D. Ball (2001)
Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 1
Sarah Landis, Taylor Murray, Sherry Bolden, P. Wingo (1999)
Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 49
G. Herder, H. Kramer, O. Hoekstra, E. Smit, J. Pruim, H. Tinteren, E. Comans, P. Verboom, C. Groot, Alle Welling, M. Paul, M. Boers, P. Postmus, G. Teule, H. Groen (2006)
Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 12
C. Plathow, P. Aschoff, M. Lichy, S. Eschmann, T. Hehr, I. Brink, C. Claussen, C. Pfannenberg, H. Schlemmer (2008)
Positron Emission Tomography/Computed Tomography and Whole-Body Magnetic Resonance Imaging in Staging of Advanced Nonsmall Cell Lung Cancer—Initial ResultsInvestigative Radiology, 43
J. Konishi, K. Yamazaki, E. Tsukamoto, N. Tamaki, Y. Onodera, Toshiyuki Otake, T. Morikawa, I. Kinoshita, H. Dosaka-akita, M. Nishimura (2003)
Mediastinal Lymph Node Staging by FDG-PET in Patients with Non-Small Cell Lung Cancer: Analysis of False-Positive FDG-PET FindingsRespiration, 70
N. Dubrawsky (1989)
Cancer statisticsCA: A Cancer Journal for Clinicians, 39
S. Shim, K. Lee, Byung‐Tae Kim, M. Chung, Eun Lee, Joungho Han, J. Choi, O. Kwon, Y. Shim, Seonwoo Kim (2005)
Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.Radiology, 236 3
ORIGINAL ARTICLE Evaluation of F-FDG PET-CT for Differentiation of Pulmonary Pathology in an Approach of Outpatient Fast Track Assessment Tjeerd S. Aukema, MD,* Renato A. Valde´s Olmos, MD, PhD,* Houke M. Klomp, MD, PhD,† Hendrik J. Teertstra, MD,‡ Jose´ S. A. Belderbos, MD, PhD,§ Wouter V. Vogel, MD, PhD,* Paul Baas, MD, PhD, Sjaak A. Burgers, MD, PhD, and Michel M. van den Heuvel, MD, PhD Key Words: Positron-Emission Tomography, Lung Neoplasms, Introduction: The aim of our study was to evaluate the clinical Diagnosis, Fast-track assessment. performance/ implementation of integrated F-fluorodeoxyglucose (J Thorac Oncol. 2009;4: 1226–1230) positron emission tomography (PET)/computed tomography (CT) for differentiation of pulmonary pathology in an approach of out- patient fast track assessment. ung cancer is the leading cause of cancer death worldwide Methods: A prospective study was performed in 114 consecutive Lwith a poor 5-year survival rate of 15%. Non-small cell patients with pulmonary symptoms and/or abnormal chest x-ray lung cancer (NSCLC) accounts for approximately 80% of were referred for fast track assessment to the Netherlands Cancer newly diagnosed patients with lung cancer. In the manage- Institute from March 2005 to September 2007. The presence of ment of malignancies, a shift to a multidisciplinary model
Journal of Thoracic Oncology – Wolters Kluwer Health
Published: Oct 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.